Final steps for EMA’s clinical-trial data policy

Clinical-trial data policy is one of the initiatives in the EU to increase transparency of clinical trials. 

A final round of consultations about EMA’s draft policy on proactive publication of and access to clinical-trial data will be held at the beginning of May. EMA and stakeholders will discuss outstanding issues before the final policy is presented to the EMA's Management Board. This consultation is necessary to arrange and clarify specific aspects and achieve the broadest possible consensus and understanding of the policy.

Original source


Register for receiving PharmaAround news, register for PharmAround events.
Continue registration